Cited 0 times in
Delays in Intracerebral Hemorrhage Management Is Associated with Hematoma Expansion and Worse Outcomes: Changes in COVID-19 Era
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김용배 | - |
dc.contributor.author | 김준형 | - |
dc.contributor.author | 박근영 | - |
dc.contributor.author | 박상규 | - |
dc.contributor.author | 이우성 | - |
dc.contributor.author | 이재환 | - |
dc.contributor.author | 장창기 | - |
dc.contributor.author | 정준호 | - |
dc.contributor.author | 한현진 | - |
dc.date.accessioned | 2021-12-28T17:13:18Z | - |
dc.date.available | 2021-12-28T17:13:18Z | - |
dc.date.issued | 2021-10 | - |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/186993 | - |
dc.description.abstract | Purpose: The coronavirus disease 2019 (COVID-19) pandemic disrupted the emergency medical care system worldwide. We analyzed the changes in the management of intracerebral hemorrhage (ICH) and compared the pre-COVID-19 and COVID-19 eras. Materials and methods: From March to October of the COVID-19 era (2020), 83 consecutive patients with ICH were admitted to four comprehensive stroke centers. We retrospectively reviewed the data of patients and compared the treatment workflow metrics, treatment modalities, and clinical outcomes with the patients admitted during the same period of pre-COVID-19 era (2017-2019). Results: Three hundred thirty-eight patients (83 in COVID-19 era and 255 in pre-COVID-19 era) were included in this study. Symptom onset/detection-to-door time [COVID-19; 56.0 min (34.0-106.0), pre-COVID-19; 40.0 min (27.0-98.0), p=0.016] and median door to-intensive treatment time differed between the two groups [COVID-19; 349.0 min (177.0-560.0), pre-COVID-19; 184.0 min (134.0-271.0), p<0.001]. Hematoma expansion was detected more significantly in the COVID-19 era (39.8% vs. 22.1%, p=0.002). At 3-month follow-up, clinical outcomes of patients were worse in the COVID-19 era (Good modified Rankin Scale; 33.7% in COVID19, 46.7% in pre-COVID-19, p=0.039). Conclusion: During the COVID-19 era, delays in management of ICH was associated with hematoma expansion and worse outcomes. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Yonsei University | - |
dc.relation.isPartOf | YONSEI MEDICAL JOURNAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | COVID-19* | - |
dc.subject.MESH | Cerebral Hemorrhage / epidemiology | - |
dc.subject.MESH | Cerebral Hemorrhage / therapy | - |
dc.subject.MESH | Hematoma / epidemiology | - |
dc.subject.MESH | Hematoma / therapy | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | SARS-CoV-2 | - |
dc.title | Delays in Intracerebral Hemorrhage Management Is Associated with Hematoma Expansion and Worse Outcomes: Changes in COVID-19 Era | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Neurosurgery (신경외과학교실) | - |
dc.contributor.googleauthor | Hyun Jin Han | - |
dc.contributor.googleauthor | Keun Young Park | - |
dc.contributor.googleauthor | Junhyung Kim | - |
dc.contributor.googleauthor | Woosung Lee | - |
dc.contributor.googleauthor | Yun Ho Lee | - |
dc.contributor.googleauthor | Chang Ki Jang | - |
dc.contributor.googleauthor | Kwang-Chun Cho | - |
dc.contributor.googleauthor | Sang Kyu Park | - |
dc.contributor.googleauthor | Joonho Chung | - |
dc.contributor.googleauthor | Young Sub Kwon | - |
dc.contributor.googleauthor | Yong Bae Kim | - |
dc.contributor.googleauthor | Jae Whan Lee | - |
dc.contributor.googleauthor | So Yeon Kim | - |
dc.identifier.doi | 10.3349/ymj.2021.62.10.911 | - |
dc.contributor.localId | A00743 | - |
dc.contributor.localId | A06047 | - |
dc.contributor.localId | A01442 | - |
dc.contributor.localId | A06166 | - |
dc.contributor.localId | A05004 | - |
dc.contributor.localId | A03088 | - |
dc.contributor.localId | A04794 | - |
dc.contributor.localId | A03731 | - |
dc.contributor.localId | A05067 | - |
dc.relation.journalcode | J02813 | - |
dc.identifier.eissn | 1976-2437 | - |
dc.identifier.pmid | 34558870 | - |
dc.subject.keyword | COVID-19 | - |
dc.subject.keyword | hemorrhage | - |
dc.subject.keyword | incidence | - |
dc.subject.keyword | stroke | - |
dc.contributor.alternativeName | Kim, Yong Bae | - |
dc.contributor.affiliatedAuthor | 김용배 | - |
dc.contributor.affiliatedAuthor | 김준형 | - |
dc.contributor.affiliatedAuthor | 박근영 | - |
dc.contributor.affiliatedAuthor | 박상규 | - |
dc.contributor.affiliatedAuthor | 이우성 | - |
dc.contributor.affiliatedAuthor | 이재환 | - |
dc.contributor.affiliatedAuthor | 장창기 | - |
dc.contributor.affiliatedAuthor | 정준호 | - |
dc.contributor.affiliatedAuthor | 한현진 | - |
dc.citation.volume | 62 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 911 | - |
dc.citation.endPage | 917 | - |
dc.identifier.bibliographicCitation | YONSEI MEDICAL JOURNAL, Vol.62(10) : 911-917, 2021-10 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.